TG Therapeutics reported 1.78M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.78M 332K
Abbvie ABBV:US $ 9517M 1089M
Amgen AMGN:US $ 4677M 451M
Ardelyx ARDX:US $ 0.38M 0.65M
Bayer BAYN:GR 9.46B 2.03B
Biogen BIIB:US $ 1777.9M 295.8M
Corcept Therapeutics CORT:US $ 92.44M 5.03M
Curis CRIS:US $ 1.98M 1M
Dynavax Technologies DVAX:US $ 74.03M 47.03M
Gilead Sciences GILD:US $ 5166M 549M
Infinity Pharmaceuticals INFI:US $ 0.26M 0.08M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Johnson & Johnson JNJ:US $ 15828M 1021M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
Novartis NOVN:VX 9.06B 463M
Ptc Therapeutics PTCT:US $ 138.6M 17.3M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M